2025 ahead ayondo Franchise coming soon
Happy 
xMas Holidays
xMas Holidays
xMas Holidays
CHICAGO, Oct. 15, 2024 /PRNewswire/ -- Trading Technologies International, Inc. (TT), a global capital markets technology platform provider, today announced the firm has been recognized as one of the world's top risk and compliance technology providers in the Chartis RiskTech100® 2025 rankings. The report, released in conjunction with a virtual event on Oct. 9, highlighted TT as the fourth best new entrant among the 22 firms that debuted this year in the rankings.
BANGKOK, Sept. 13, 2024 /PRNewswire/ -- Thermo King, a strategic brand of Trane Technologies (NYSE: TT), a global climate innovator, has announced a significant upgrade to its high-roof truck solutions for RV1200/1100/1000S ultra-slim, vehicle- powered truck refrigeration units.
Specifically designed for heavy-duty refrigeration trucks, this high-roof series has achieved remarkable success in the market with its excellent performance and high reliability since its launch in 2022. With this new upgrade, Thermo King has introduced comprehensive innovations spanning from product design to production efficiency. The upgrade not only expands the driver's cab of the refrigeration truck by up to 20%, but also significantly enhances the energy efficiency by 20%. This series offers the cold chain transportation industry an innovative experience that combines superior performance with lower costs. Looking ahead, the series is set to enter more markets, such as Singapore and Malaysia.
SINGAPORE, Sept. 13, 2024 /PRNewswire/ -- Thermo King, a strategic brand of Trane Technologies (NYSE: TT), a global climate innovator, has announced a significant upgrade to its high-roof truck solutions for RV1200/1100/1000S ultra-slim, vehicle- powered truck refrigeration units.
Specifically designed for heavy-duty refrigeration trucks, this high-roof series has achieved remarkable success in the market with its excellent performance and high reliability since its launch in 2022. With this new upgrade, Thermo King has introduced comprehensive innovations spanning from product design to production efficiency. The upgrade not only expands the driver's cab of the refrigeration truck by up to 20%, but also significantly enhances the energy efficiency by 20%. This series offers the cold chain transportation industry an innovative experience that combines superior performance with lower costs. Looking ahead, the series is set to enter more markets, such as Singapore and Malaysia.
ALAMEDA, Calif. and TAIPEI, Sept. 3, 2024 /PRNewswire/ -- Acepodia (6976:TT), a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) and allogeneic gamma delta 2 (γδ2) T cell platforms, announced today that it has entered a strategic clinical collaboration with Pfizer Ignite to support the development of its therapies in autoimmune diseases. Pfizer Ignite is an end-to-end offering that leverages Pfizer's significant resources, scale, and expertise, alongside a proven track record in the development of breakthroughs, to support biotechs seeking to accelerate their innovations from preclinical R&D through the development lifecycle. Under this new agreement, Pfizer Ignite will provide strategic guidance and resources to Acepodia as the company develops its cell therapies for oncology and autoimmune diseases.
SHANGHAI, Aug. 9, 2024 /PRNewswire/ -- Trane® - by Trane Technologies (NYSE: TT), a global climate innovator, announces its new GEN Elite C Series VRF system, a Cooling Only Variable Refrigerant Flow (VRF) system is available for India, Thailand, Vietnam and other emerging markets in the Asia Pacific region. The breakthrough system offers high efficiency, precise temperature control, stable performance, and a flexible design, making it an ideal solution for a wide range of commercial buildings including offices, hospitals, retail spaces, and more.
Highlights (second-quarter 2024 versus second-quarter 2023, unless otherwise noted): Reported revenues of $5.3 billion, up 13 percent; organic revenues* up 13 percent GAAP operating margin up 70 bps; adjusted operating margin* up 140 bps Adjusted EBITDA margin* of 21.1 percent, up 140 bps GAAP continuing EPS of $3.33; adjusted continuing EPS* of $3.30, up 23 percent Bookings* up 19 percent, led by Americas Commercial HVAC, up 21 percent
*This news release contains non-GAAP financial measures. Definitions of the non-GAAP financial measures can be found in the footnotes of this news release. See attached tables for additional details and reconciliations.
Modular Design Leads to New Experience of Convenient Installation
SHANGHAI, July 11, 2024 /PRNewswire/ -- Trane®, a strategic brand of Trane Technologies (NYSE: TT), a global climate innovator, announced the launch of the revolutionary Climate Changer Magicube (CLCM) air handling unit to address the challenges associated with the installation and maintenance of air conditioning equipment in modern buildings. Featuring with an innovative modular design, the CLCM unit simplifies installation and maintenance processes significantly, which also effectively reduces the cost associated with constructing, operating and maintaining the building's air-conditioning system, and creates a clean and comfortable environment with high-quality air for users.
Company's latest ESG report highlights reduction of 157 million metric tons of customers' carbon emissions and 44% reduction in operational emissions since 2019 while significantly increasing earnings per share
SWORDS, Ireland, May 31, 2024 /PRNewswire/ -- Trane Technologies (NYSE: TT), a global climate innovator, is accelerating growth and delivering continued, industry-leading financial performance while advancing the company's bold 2030 Sustainability Commitments.
ALAMEDA, Calif. and TAIPEI, May 8, 2024 /PRNewswire/ -- Acepodia (6976:TT), a clinical stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) and allogeneic gamma delta 2 (γδ2) T cell platforms to address gaps in cancer care, today announced preliminary data from its Phase 1 dose escalation clinical trial of ACE1831, an anti-CD20 antibody conjugated allogeneic gamma delta T cell therapy being evaluated in patients with non-Hodgkin's lymphoma (NHL).
Highlights (first-quarter 2024 versus first-quarter 2023, unless otherwise noted):
Reported revenues of $4.2 billion, up 15 percent; organic revenues* up 14 percentGAAP operating margin up 250 bps; adjusted operating margin* up 230 bpsAdjusted EBITDA margin* of 16.8 percent, up 200 bpsGAAP continuing EPS of $1.92; adjusted continuing EPS* of $1.94, up 38 percentOrganic bookings* up 17 percent, led by Americas Commercial HVAC, up 30 percent$7.7 billion backlog, up 10 percent versus year-end 2023, and over 2.5 times historical normsThe information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.
RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.
Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.
On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.
